tirzepatide in children

tirzepatide in children Once Weekly and Adolescents with Type 2 Diabetes (SURPASS-Peds). The New England Journal of Medicine. 2024;391:XXX–XXX. doi:10.1056/NEJMoa2400938 tirzepatide adolescent obesity trial Efficacy

Name: tirzepatide in children Once Weekly and Adolescents with Type 2 Diabetes (SURPASS-Peds). The New England Journal of Medicine. 2024;391:XXX–XXX. doi:10.1056/NEJMoa2400938 tirzepatide adolescent obesity trial Efficacy
Brand: 2m-capital.com
SKU: 74495338495
Price: 22.10 USD
Availability: InStock
Rating: 4.2916 (28 reviews)

SKU: 74495338495

4.3

USD22.10 USD64.10

Pay in 4 interest-free payments of $5.53 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 16 - Nov 21

Description

Kohjin Life Sciences Co., Ltd

Tirzepatide (brand names Mounjaro and Zepbound): A dual-action medication that activates both GLP-1 and GIP receptors, tirzepatide has demonstrated even more impressive weight loss outcomes, with studies showing average weight loss of 15.0% to 20.9% of body weight

It requires prescriber judgment informed by your specific lipid profile, cardiovascular history, and response to therapy